Innovation in 3D <em>in vitro</em> oncology

Insphero offers advanced 3D in vitro technology for immuno-oncology screening, and presents the 3D InSight™ Tumor Microtissue in the assessment of Antibody-Drug Conjugates (ADCs) efficacy and penetration depth. InSphero further highlights the product's capabilities including the evaluation of various therapeutic modalities, such as antibody-based therapeutics, with confidence, covering mechanisms of action, immune cell engagement, off-target effects, and more.